Investment Column: Testing time for SHL
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.FOR A company whose main function is psychometric testing for employment purposes, SHL has been spectacularly poor at analysing its own business prospects. Floated at 245p in October SHL has managed to fit two profits warnings into its brief stock market life. Yesterday's broadside knocked 45 per cent off the shares, taking them to 144p, well below the issue price.
The problem is America. The group has been guilty of over-optimism on sales. The conversion of prospects into revenues has been lower than expected, leading to a pounds 1.6m first-half loss in the US compared to a small profit last time. A new chief operating officer has been appointed to help turn the situation around and costs are being trimmed.
It was the poor US performance that restricted first half profits to pounds 4.5m, down from the previous year's pounds 4.8m. Elsewhere the Meridian business in the UK and Ireland grew profits by more than 40 per cent, as did the European operation.
SHL's house broker has revised its full year forecast from pounds 12.3m to pounds 10m. That puts the shares on a suitably modest forward rating of around 14. It is too late for existing shareholders to sell now. For others the stock may look cheap but after two profits warnings SHL needs at least two good sets of figures to restore its damaged credibility. Potentially good value, but there is no rush.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments